A phase 1 clinical study of PL7737 for obesity
Latest Information Update: 24 Nov 2024
Price :
$35 *
At a glance
- Drugs Obesity therapies (Primary)
- Indications Obesity
- Focus Adverse reactions
- 24 Nov 2024 New trial record
- 14 Nov 2024 According to a Palatin Technologies Inc. media release, Filing of INDs anticipated 2H of calendar year 2025 and commencement of Phase 1 clinical study targeted for 4Q of calendar year 2025.